Oral Solid Dose
-
Minitabs Technology
8/29/2024
Discover a multiparticulate system that provides unparalleled flexibility in dosage forms, which allows you to create customized release profiles, precise dosing, and a wide range of delivery options.
-
The Future Of Oral Solid Dose Development And Innovation
2/27/2025
Tom Sellig, CEO of Adare, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.
-
Future Of Pharma Packaging: Trends, Tech, And Patient Solutions
9/25/2025
Explore how traditional and innovative pharmaceutical packaging formats improve patient adherence, support emerging therapies, and shape the future of drug delivery and treatment outcomes.
-
Challenges With Pediatric Flavors For Taste Enhancement And Modulation
3/17/2022
Taste masking for children can present unique challenges for drug developers. Learn how we can use flavor, not just to provide a desired taste, but also to provide taste masking.
-
Taste Masking 101: Optimize Taste And Improve Patient Outcomes
6/28/2021
Learn how swallowability and palatability play key factors related to patient acceptability and product development and about the variety of taste masking strategies including excipients, organoleptic and barrier coating approaches, and microencapsulation technologies.
-
Diffucaps Technology
8/29/2024
Discover how Diffucaps technology offers precise drug release, tailored dosage, and enhanced solubility, while minimizing irritation.
-
OSD Manufacturing For Pediatrics And Other Special Patient Populations
8/29/2024
Watch to hear Steven Facer, Adare's Vice President of Business Development EU/ROW, discuss the challenges of pediatric oral solid dose manufacturing and how to overcome them.
-
The Future Of Blister Packaging
8/29/2024
Maximize your productivity and efficiency with a versatile solution for inline cartoning, bundling, case packing, and pallet loading that also includes thermo and cold forming options to accommodate diverse packaging needs.
-
Patient- And Planet-Centric Bioavailability And Sustained Delivery
By reducing the size of drug particles, nanoforming offers new opportunities — from increased bioavailability to sustained drug delivery. Discover the potential benefits supported by case studies.
-
Advances In Oral GLP-1 Analogs For Obesity
9/12/2024
Discover how these groundbreaking Oral GLP-1 Analogs therapies are reshaping obesity management and addressing key challenges in formulation and delivery.